Hims & Hers Health, Inc. (HIMS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol HIMS
- Company Hims & Hers Health, Inc.
- Price $22.16
- Changes Percentage 40.79
- Change 6.42
- Day Low $20.99
- Day High $23.51
- Year High $70.43
- Year Low $13.74
- Market Cap $4,865,471,760
- Price Avg 50 EMA (D) $24.96
- Price Avg 200 EMA (D) $42.77
- Exchange NYSE
- Volume 168,062,056
- Average Volume 26,350,511
- Open $23.22
- Previous Close $15.74
- EPS 0.51
- PE 43.45
- Earnings Announcement 2026-05-04 20:00:00
- Shares Outstanding $219,561,000
Company brief: HIMS & HERS HEALTH, INC. (HIMS )
- Consumer Defensive
- Household & Personal Products
- Mr. Andrew Dudum
- https://www.forhims.com
- US
- N/A
- 09-13-2019
- US4330001060
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
HIMS Corporation News
Is HIMS stock the best buy in March 2026?
finbold.com -- Shares of Hims & Hers Health (NYSE: HIMS) have staged a sharp rebound after drugmaker Novo Nordisk (NYSE: NVO) dropped its lawsuit against the company, removing what many investors considered the bigg...
Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars
benzinga.com -- Novo Nordisk has decided to sell its weight-loss drug through Hims & Hers' telehealth platform, following a lawsuit over patent violations regarding a compounded version of semaglutide products....
Hims shares jump after report of Novo Nordisk partnership that may end legal feud
reuters.com -- Hims & Hers' shares were up over 50% in premarket trading on Monday following reports Novo Nordisk plans to sell its weight-loss drugs on the telehealth firm's platform, signaling a potential en...
Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.
barrons.com -- Novo has agreed to sell its weight-loss drugs on Hims' platform, according to a report....
Hims & Hers Shares Double on Report of Wegovy Tie-Up
wsj.com -- Stock skyrocketed premarket following a media report that the maker of Wegovy plans to sell the weight-loss drug on the platform....
Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
marketwatch.com -- Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant....
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
reuters.com -- Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal ba...
Hims and Hers Expands Its Technology Driven Consumer Health Platform
zacks.com -- HIMS expands its tech-driven care platform with data-led Labs testing, new menopause and testosterone services and global expansion into Canada....